Castle Biosciences

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CSTL and other ETFs, options, and stocks.

About CSTL

Castle Biosciences, Inc.is a molecular diagnostics company offering innovative test solutions to aid clinicians in the diagnosis and treatment of dermatologic cancers, barrett’s esophagus, uveal melanoma, and in the treatment of mental health conditions. The firm offers DecisionDx-Melanoma, a proprietary multi-gene expression profile (GEP) test that predicts the risk of metastasis and recurrence for patients diagnosed with invasive cutaneous melanoma.

CEO

Derek J. Maetzold

CEODerek J. Maetzold

Employees

761

Employees761

Headquarters

Friendswood, Texas

HeadquartersFriendswood, Texas

Founded

2007

Founded2007

Employees

761

Employees761

CSTL Key Statistics

Market cap

1.04B

Market cap1.04B

Price-Earnings ratio

-77.18

Price-Earnings ratio-77.18

Dividend yield

—

Dividend yield—

Average volume

614.77K

Average volume614.77K

High today

$35.49

High today$35.49

Low today

$34.64

Low today$34.64

Open price

$34.64

Open price$34.64

Volume

13.08K

Volume13.08K

52 Week high

$35.49

52 Week high$35.49

52 Week low

$14.59

52 Week low$14.59

Stock Snapshot

The current Castle Biosciences(CSTL) stock price is $35.49, with a market capitalization of 1.04B. The stock trades at a price-to-earnings (P/E) ratio of -77.18.

On 2025-11-11, Castle Biosciences(CSTL) stock moved within a range of $34.64 to $35.49. With shares now at $35.49, the stock is trading +2.5% above its intraday low and 0.0% below the session's peak.

Trading volume for Castle Biosciences(CSTL) stock has reached 13.08K, versus its average volume of 614.77K.

The stock's 52-week range extends from a low of $14.59 to a high of $35.49.

Analyst ratings

100%

of 8 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own CSTL. This list is generated using Robinhood data, and it’s not a recommendation.